Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,300
NCT00736866
The Acetylcysteine for Contrast-Induced Nephropathy Trial
Phase: Phase 3
Role: Collaborator
Start: Aug 31, 2008
Completion: Jul 31, 2010